Palivizumab labels and packages: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Palivizumab}} {{CMG}}; {{AE}} {{SS}} ==Labels And Packages== {| |- |thumb|1600px|left |- |} {| |- |File:Palivizumab 2.jpg|thumb|160...")
 
No edit summary
 
Line 7: Line 7:
{|
{|
|-
|-
|[[File:Palivizumab 1.jpg|thumb|1600px|left]]
|[[File:Palivizumab 1.jpg|thumb|1000px|left]]
|-
|-
|}
|}
Line 13: Line 13:
{|
{|
|-
|-
|[[File:Palivizumab 2.jpg|thumb|1600px|left]]
|[[File:Palivizumab 2.jpg|thumb|1000px|left]]
|-
|-
|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = SYNAGIS (PALIVIZUMAB) INJECTION, SOLUTION [MEDIMMUNE, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e35c4c8-bf56-458f-a73c-8f5733829788#nlm34089-3 | publisher =  | date =  | accessdate = 8 January 2014 }}</ref>
|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = SYNAGIS (PALIVIZUMAB) INJECTION, SOLUTION [MEDIMMUNE, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e35c4c8-bf56-458f-a73c-8f5733829788#nlm34089-3 | publisher =  | date =  | accessdate = 8 January 2014 }}</ref>

Latest revision as of 04:53, 8 January 2014

Palivizumab
SYNAGIS® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels And Packages

[1]

References

  1. "SYNAGIS (PALIVIZUMAB) INJECTION, SOLUTION [MEDIMMUNE, LLC]". Retrieved 8 January 2014.

Adapted from the FDA Package Insert.